FMP

FMP

Blog
Screener
Extras

TRIL - Trillium Therapeutics Inc.

Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a S

photo-url-https://financialmodelingprep.com/image-stock/TRIL.jpg

Trillium Therapeutics Inc.

TRIL

NASDAQ

18.44 USD

0 (0.00%)

About

ceo

Dr. Jan Skvarka

sector

Healthcare

industry

Biotechnology

website

http://trilliumtherapeutics.com

exchange

NASDAQ

Description

Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. Its product candidates also include TTI-622 that is in Phase I clinical trial of immunoglobulin G4 SIRPaFc protein; and TTI-10001, a small molecule stimulator of interferon genes agonist that senses cytosolic DNA for promoting tumor immunity, which is in the discovery Phase. The company was...

CIK

0001616212

ISIN

CA89620X5064

CUSIP

89620X506

Address

2488 Dunwin Dr

Phone

14165950627

Country

CA

Employee

33

IPO Date

Jan 11, 2005

Summary

CIK

0001616212

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

89620X506

ISIN

CA89620X5064

Country

CA

Price

18.44

Beta

1.9

Volume Avg.

1.98M

Market Cap

0

Shares

-

52-Week

17.83-18.49

DCF

21.39

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

0

P/B

-

Website

http://trilliumtherapeutics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest TRIL News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep